Research Institute for Future medicine
Research Institute for Future medicine

Samsung Medical Center established the Research Center for Future Medicine in July 2010 to advance clinical research and grow into one of the world’s leading research driven hospitals. In November 2011, the Samsung Medical Center merged Samsung Biomedical Research Institute and Research Center for Future Medicine to launch the Research Institute for Future Medicine.

Since then, the Research Institute for Future Medicine has been actively implementing creative clinical research by providing a wide range of research support system. Thanks to these efforts, the institute is reinforcing its network with global medical centers, and is leading the advancement of future medicine by exporting avatar research technology to the Middle East.

The institute will continue to nurture clinical research specialists, innovate clinical trial infrastructure specializing in critical illnesses including cancer and establish open innovation network with global pharmaceutical companies and research institutes.

History

2015
Feb
  • Established MOU for genome-based personalized cancer treatment and development with Tgen
2014
Dec
  • Designated as Systems and R&D Budget Support Program among research driven hospital
  • Designated as Medical Device Translational Clinical Trial Center
Nov
  • Designated as Global Center of Excellence in Early Clinical Trials
  • Signed agreement with King Fahad Medical City, Saudi Arabia for refractory cancer research
  • Launched brain tissue bank
2013
Sep
  • Established Stem Cell & Regenerative Medicine Center
Apr
  • Designated as Research Driven Hospital
Mar
  • Established Samsung Genome Institute
2012
Sep
  • Designated as premier research site by Sanofi-Aventis Korea
2009
Sep
  • Hosted the first Korea-Japan Joint Forum of Medical Device Clinical Trial
2008
Oct
  • Designated as Medical Device Clinical Trial Center by the Ministry for Health, Welfare and Family Affairs
2006
Jun
  • Acquired full accreditation by the Association for the Accreditation of Human Research Protection Programs (AAHRPP) for the first time outside of the United States
2005
Feb
  • Opened and launched e-IRB system (Korea’s first; currently 31 hospitals are using the SMC system)
2003
Oct
  • Established Clinical Trial Training Center
2002
Aug
  • Developed IRB Standard Operation Protocol (SOP)
Jun
  • Acquired Federal Clinical Trial Practicing Entity FWA Certification (FWA: Federal Wide Assurance)
2001
May
  • Established Clinical Trial Pharmacy
Jan
  • Registered as IRB and FWA to the U.S. Department of Health and Human Service
1998
Dec
  • Established Clinical Research Institute